The novel beta 2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells

Kraus, M.; Bader, J.; Geurink, P.P.; Weyburne, E.S.; Mirabella, A.C.; Silzle, T.; ... ; Driessen, C. (2015)

Article / Letter to editor

• All authors: Kraus, M.; Bader, J.; Geurink, P.P.; Weyburne, E.S.; Mirabella, A.C.; Silzle, T.; Shabaneh, T.B.; Linden, W.A. van der; Bruin, G. de; Haile, S.R.; Rooden, E. van; Appenzeller, C.; Li, N.; Kisselev, A.F.; Overkleeft, H.; Driessen, C.
• Date: 2015-10-31
• Journal: Haematologica
• Volume: 100
• Issue: 10
• Pages: 1350 - 1360
• DOI: doi:10.3324/haematol.2014.109421